PARG and colorectal carcinoma: Moreover, adavosertib decreased cell survival of CRC cell line (HCT116) in combination to PARG inhibitor (PDDX-004/PDD00017272) in vitro, and in PARG knockout cell clones (HCT116 PARG KO) in xenograft model by induction of DNA damage in S-phase [148].